Sélectionnez l'édition
Pays
Objectif principal
Maladie
Type d'Organisation
Partie prenante
Qualité
Advocacy (policy advocacy, lobbying)
Musculoskeletal/Multiple Sclerosis (MS) (1)
Pharmaceutical, Biotech, Medical Device Company (0)
Payers (usually governmental or public bodies, reimbursement)
Capacity and capabilities for engagement
Clinical study phase I